Amelioration of ischemia- and reperfusion-induced myocardial injury by 17β-estradiol: Role of nitric oxide and calcium-activated potassium channels

Circulation

Volumn 96, Issue 6, 1997, Pages 1953-1963

  Node, Koichi ^a   Kitakaze, Masafumi ^a   Kosaka, Hiroaki ^a   Minamino, Tetsuo ^a   Funaya, Hiroharu ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Endothelium derived factors; Hormones; Ischemia; Myocardial infarction; Reperfusion

Indexed keywords

CALCIUM ION; CYCLIC GMP; ESTRADIOL; IBERIOTOXIN; INDOMETACIN; LACTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; OXIDOPAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROPRANOLOL; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CHANNEL GATING; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DOG; DRUG EFFECT; HEART DENERVATION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE ARRHYTHMIA; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0030819430     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1953     Document Type: Article

References (32)

1. Stampfer MJ, Colditz GA, Wilett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year results from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
2. Vargas R, Worblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
3. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133-136.
4. Van Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992;167: 828-833.
5. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72: 403-412.
6. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun. 1995;211:370-374.
7. Yao SK, Akhtar S, Burden TS, Ober JC, Golino P, Buja LM, Casscells W, Willerson JT. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation. 1995;92:1005-1010.
8. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T. Increased release of NO during ischemia decreases myocardial contractility and improves metabolic dysfunction. Circulation. 1996;93:356-364.
9. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992; 70:607-611.
10. Tohse N, Sperelakis N. cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ Res. 1991;69:325-331.
11. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting action of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 1993;88:2337-2350.
12. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979;100:375-382.
13. + channels. Biochem Biophys Res Commun. 1995;214: 367-372.
14. Walker MJA, Curtis MJ, Hearse DJ. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 1988;22:447-455.
15. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
16. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J Clin Endocrinol Metab. 1972;34:312-318.
17. + channels regulates coronary blood flow in ischemic myocardium. Circulation. 1997;95:1560-1567.
18. Iversen LL. Catecholamine uptake processes. Br Med Bull. 1973; 29:130-135.
19. Mori H, Haruyama S, Shinozaki Y, Okino H, Iida A, Takanashi R, Sakura I, Husseini W, Payne B, Hoffman JIE. New nonradioactive microspheres and more sensitive x-ray fluorescence to measure regional blood flow. Am J Physiol. 1992;263:H1946-H1957.
20. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal woman. Lancet. 1994;343:269-270.
21. 2 in porcine coronary artery. Circulation. 1995;91:2619-2626.
22. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 1992;106:739-745.
23. Ca channels through a cGMP-dependent mechanism. Circ Res. 1995;77:936-942.
24. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 1990;27:238-245.
25. 2+ current: involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem. 1993;268:26286-26295.
26. Depre C, Vanoverschelde JL, Goudemant JF, Mottet R, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 1995;92:1911-1918.
27. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
28. McHugh NA, Cook SM, Schairer JL, Bidgoli MM, Merrill GF. Ischemia and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol. 1995;268:H2569-H2573.
29. Opie LH. Role of cyclic nucleotides in heart metabolism. Cardiovasc Res. 1982;16:483-507.
30. Krause EG, Ziegelhoffer A, Fedelsova M, Styk J, Kostolanski S, Gabauer I, Blasig I, Wollenberger A. Myocardial cyclic nucleotide levels following coronary artery ligation. Adv Cardiol. 1978;25: 119-129.
31. Daugherty A, Woodward B. Effects of carbachol and dibutyryl cyclic GMP on the vulnerability to ventricular fibrillation in rat isolated hearts. Br J Pharmacol. 1985;85:621-627.
32. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol. 1995;26:807-814.